Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Hugel Control

Biotech & Life Sciences · Seoul, South Korea · Founded 2001 · IPO 2016 Thoroughbred

Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products

Valuation
$1.86B
Market cap · May/2026
Revenue
$356M
Latest reported FY
EBITDA
$193M
Latest reported FY

Global footprint

Where Hugel Control has talent and traffic

Workforce by country
6 countries with
team presence
🇰🇷 South Korea89.7%
🇨🇦 Canada3.2%
🇺🇸 United States2.4%
🇦🇺 Australia1.6%
🇹🇼 Taiwan1.6%
Top 5 of 6 shown
Web traffic by country
16K monthly visits
across markets
🏳️ Korea33.1%
🏳️ Republic of0%
Top 2 markets shown

Market sentiment

What the market is saying about Hugel Control

An AI-synthesized read of the highest-engagement posts about Hugel Control on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hugel Control on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.